Clinical Trial Update: Safety Study of Liver Natural Killer Cell Therapy for Hepatoma Liver Transplantation [Phase 1]

View source ↗

Summary

Phase 1 safety study of liver natural killer (NK) cell therapy in patients undergoing liver transplantation for hepatocellular carcinoma; results have been post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Cirrhosis

Drugs mentioned

• Liver Natural Killer Cell Therapy

Snippet

Sponsor: Seigo Nishida | Conditions: Liver Cirrhosis, Hepatocellular Carcinoma | Phase 1 | Status: COMPLETED | Results posted: 2016-03-10